Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 4
1989 2
1990 2
1991 5
1992 1
1993 5
1994 5
1995 12
1996 13
1997 9
1998 6
1999 4
2000 9
2001 8
2002 7
2003 8
2004 13
2005 11
2006 8
2007 4
2008 2
2009 5
2010 7
2011 9
2012 10
2013 8
2014 11
2015 13
2016 12
2017 19
2018 16
2019 8
2020 14
2021 22
2022 22
2023 19
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

307 results

Results by year

Filters applied: . Clear all
Page 1
Asymptomatic ceftriaxone-associated pseudolithiasis.
Sasaki O, Sugimura K, Shinoda M, Shinkai M. Sasaki O, et al. Among authors: shinkai m. J Gen Fam Med. 2019 Jul 12;20(5):209-212. doi: 10.1002/jgf2.269. eCollection 2019 Sep. J Gen Fam Med. 2019. PMID: 31516810 Free PMC article.
Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical Trial.
Martinez FJ, Criner GJ, Gessner C, Jandl M, Scherbovsky F, Shinkai M, Siler TM, Vogelmeier CF, Voves R, Wedzicha JA, Bartels C, Bottoli I, Byiers S, Cardenas P, Eckert JH, Gutzwiller FS, Knorr B, Kothari M, Parlikar R, Tanase AM, Franssen FME. Martinez FJ, et al. Among authors: shinkai m. Am J Respir Crit Care Med. 2023 Aug 15;208(4):417-427. doi: 10.1164/rccm.202303-0458OC. Am J Respir Crit Care Med. 2023. PMID: 37411039 Free PMC article. Clinical Trial.
Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain.
Takano T, Sato T, Kotaki R, Moriyama S, Fukushi S, Shinoda M, Kabasawa K, Shimada N, Kousaka M, Adachi Y, Onodera T, Terahara K, Isogawa M, Matsumura T, Shinkai M, Takahashi Y. Takano T, et al. Among authors: shinkai m. Nat Commun. 2023 Mar 15;14(1):1451. doi: 10.1038/s41467-023-37128-1. Nat Commun. 2023. PMID: 36922492 Free PMC article.
Esophagectasis Related to Rivastigmine.
Sasaki O, Sugimura K, Shinoda M, Shinkai M. Sasaki O, et al. Among authors: shinkai m. Intern Med. 2019 May 15;58(10):1527. doi: 10.2169/internalmedicine.2137-18. Epub 2019 Jan 10. Intern Med. 2019. PMID: 30626841 Free PMC article. No abstract available.
Macrolides and airway inflammation in children.
Shinkai M, Rubin BK. Shinkai M, et al. Paediatr Respir Rev. 2005 Sep;6(3):227-35. doi: 10.1016/j.prrv.2005.06.005. Paediatr Respir Rev. 2005. PMID: 16153572 Review.
Amide-to-ester substitution as a stable alternative to N-methylation for increasing membrane permeability in cyclic peptides.
Hosono Y, Uchida S, Shinkai M, Townsend CE, Kelly CN, Naylor MR, Lee HW, Kanamitsu K, Ishii M, Ueki R, Ueda T, Takeuchi K, Sugita M, Akiyama Y, Lokey SR, Morimoto J, Sando S. Hosono Y, et al. Among authors: shinkai m. Nat Commun. 2023 Mar 17;14(1):1416. doi: 10.1038/s41467-023-36978-z. Nat Commun. 2023. PMID: 36932083 Free PMC article.
COVID-19 pneumonia and an indelible ground-glass nodule.
Yamanaka S, Ota S, Yoshida Y, Shinkai M. Yamanaka S, et al. Among authors: shinkai m. Respirol Case Rep. 2021 Apr 8;9(5):e00751. doi: 10.1002/rcr2.751. eCollection 2021 May. Respirol Case Rep. 2021. PMID: 33854784 Free PMC article.
307 results